Liver cancer is a severe disease worldwide. The incidence and mortality rates of liver cancer in China is the highest in the world. This project aims to perform a prospective, multi-center, large sample cohort study for HBV related high-risk individuals. Based on multimodal data fusion and AI technique, stratified management and follow-up system are conducted for HBV-related high-risk populations of liver cancer, in order to improve the early diagnosis rate of liver cancer.
Study Type
OBSERVATIONAL
Enrollment
6,000
In AI follow-up group, patients will be followed up by an AI system.
Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
RECRUITINGNumber and specific time of participants progressing to liver cancer
Number and specific time of participants progressing to liver cancer
Time frame: 5 years
Survival time
Participants' survival time after being diagnosed with liver cancer.
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.